Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment

Blood

Volumn 121, Issue 8, 2013, Pages 1316-1325

  Yamauchi, Takuji ^a   Takenaka, Katsuto ^a   Urata, Shingo ^a   Shima, Takahiro ^a   Kikushige, Yoshikane ^a   Tokuyama, Takahito ^a   Iwamoto, Chika ^a   Nishihara, Mariko ^a   Iwasaki, Hiromi ^b   Miyamoto, Toshihiro ^a   Honma, Nakayuki ^c   Nakao, Miki ^d   Matozaki, Takashi ^e   Akashi, Koichi ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; RAG1 PROTEIN; RAG2 PROTEIN; SIRPA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; C57BL 6 MOUSE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ENGRAFTMENT; GENETIC POLYMORPHISM; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; XENOGRAFT;

EID: 84874424080     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-440354     Document Type: Article

References (48)

1. Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapyresistant human AMLstem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25(11):1315-1321. (Pubitemid 350076512)
2. Manz MG, Di Santo JP. Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol. 2009;10(10):1039-1042.
3. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997;94(10):5320-5325. (Pubitemid 27214781)
4. Guenechea G, Gan OI, Dorrell C, Dick JE. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol. 2001;2(1):75-82. (Pubitemid 33704957)
5. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66(19):9339-9344. (Pubitemid 44623625)
6. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol. 2007;18(5):460-466. (Pubitemid 350116595)
7. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730-737. (Pubitemid 27298715)
8. Kikushige Y, Ishikawa F, Miyamoto T, et al. Selfrenewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 2011;20(2):246-259.
9. Greiner DL, Hesselton RA, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells. 1998;16(3):166-177. (Pubitemid 28235161)
10. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241(4873):1632-1639.
11. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154(1):180-191.
12. Shultz LD, Lang PA, Christianson SW, et al. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol. 2000;164(5):2496-2507. (Pubitemid 30115479)
13. Shultz LD, Banuelos S, Lyons B, et al. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation. 2003;76(7):1036-1042. (Pubitemid 37280830)
14. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/SCID/gamma (c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175-3182. (Pubitemid 35217065)
15. Shultz LD, Lyons BL, Burzenski LM, et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477-6489. (Pubitemid 40663843)
16. Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain-(null) mice. Blood. 2005;106(5):1565-1573. (Pubitemid 41208567)
17. + T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol. 1997;158(8):3578-3586. (Pubitemid 127488709)
18. Kollet O, Peled A, Byk T, et al. beta2 microglobulindeficient (B2m (null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood. 2000;95(10):3102-3105. (Pubitemid 30321160)
19. Ishikawa F, Livingston AG, Wingard JR, Nishikawa S, Ogawa M. An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin (null) mice. Exp Hematol. 2002;30(5):488-494. (Pubitemid 34556741)
20. Pearson T, Shultz LD, Miller D, et al. Non-obese diabetic-recombination activating gene-1 (NODRag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol. 2008;154(2):270-284.
21. Brehm MA, Cuthbert A, Yang C, et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma (null) mutation. Clin Immunol. 2010;135(1):84-98.
22. Gorantla S, Sneller H, Walters L, et al. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/-mice. J Virol. 2007;81(6):2700-2712. (Pubitemid 46447035)
23. Christianson SW, Greiner DL, Schweitzer IB, et al. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell Immunol. 1996;171(2):186-199. (Pubitemid 26268474)
24. Takenaka K, Prasolava TK, Wang JC, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007;8(12):1313-1323. (Pubitemid 350138972)
25. Ono A, Hattori S, Kariya R, et al. Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice. J Biomed Biotechnol. 2011;2011:539748.
26. Kataoka S, Satoh J, Fujiya H, et al. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes. 1983;32(3):247-253. (Pubitemid 13138268)
27. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 1980;29(1):1-13. (Pubitemid 10185796)
28. Oldenborg PA, Gresham HD, Chen Y, Izui S, Lindberg FP. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood. 2002;99(10):3500-3504. (Pubitemid 34534515)
29. Strowig T, Rongvaux A, Rathinam C, et al. Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma (c)-/-mice improves engraftment of human hematopoietic cells in humanized mice. Proc Natl Acad Sci U S A. 2011;108(32):13218-13223.
30. Oshima K, Ruhul Amin AR, Suzuki A, Hamaguchi M, Matsuda S. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS Lett. 2002;519(1-3):1-7. (Pubitemid 34521982)
31. Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol. 2006;6(6):457-464.
32. Matozaki T, Murata Y, Okazawa H, Ohnishi H. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol. 2009;19(2):72-80.
33. Tsai RK, Discher DE. Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol. 2008;180(5):989-1003. (Pubitemid 351398424)
34. Legrand N, Huntington ND, Nagasawa M, et al. Functional CD47/signal regulatory protein alpha (SIRP (alpha)) interaction is required for optimal human T-and natural killer-(NK) cell homeostasis in vivo. Proc Natl Acad Sci U S A. 2011;108(32):13224-13229.
35. Motegi S, Okazawa H, Ohnishi H, et al. Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J. 2003;22(11):2634-2644. (Pubitemid 36712361)
36. Kuriyama T, Takenaka K, Kohno K, et al. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood. 2012;120(19):4058-4067.
37. Yahata T, Ando K, Sato T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood. 2003;101(8):2905- 2913. (Pubitemid 36857974)
38. Notta F, Doulatov S, Dick JE. Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients. Blood. 2010;115(18):3704-3707.
39. McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood. 2010;116(2):193-200.
40. Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304(5667):104-107. (Pubitemid 38451466)
41. Tanaka S, Saito Y, Kunisawa J, et al. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rgammaKO mice. J Immunol. 2012;188(12):6145-6155.
42. Baxter AG, Cooke A. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes. 1993;42(11):1574- 1578. (Pubitemid 23318112)
43. Prochazka M, Serreze DV, Frankel WN, Leiter EH. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes. 1992;41(1):98-106.
44. Iwamoto C, Takenaka K, Urata S, et al. The efficient engraftment of human hematopoiesis in the Balb/c strain is mounted by Balb/c-specific SIRPA polymorphism that enhances binding affinity to human CD47 [abstract]. Blood (ASH Annual Meeting Abstracts). 2011;118(21):4008.
45. Rongvaux A, Willinger T, Takizawa H, et al. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc Natl Acad Sci U S A. 2011;108(6):2378-2383.
46. Takagi S, Saito Y, Hijikata A, et al. Membranebound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood. 2012;119(12):2768-2777.
47. Chao MP, Alizadeh AA, Tang C, et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell. 2010;142(5):699-713.
48. Kikushige Y, Shima T, Takayanagi S, et al. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell. 2010;7(6):708-717.